Citation Impact
Citing Papers
Cancer statistics, 2022
2022 Standout
An artificial intelligence-based chatbot for prostate cancer education: Design and patient evaluation study
2023
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Cancer statistics, 2023
2023 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Testicular Pain Following Laparoscopic Renal Surgery
2008
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies
2014
Nephrectomy for benign disease in the UK : results from the British Association of Urological Surgeons nephrectomy database
2015
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Evaluation of Laparoscopic Retroperitoneal Surgery in Urinary Stone Disease
2001
Update on screening for prostate cancer with prostate-specific antigen
2004
Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors
2004 Standout
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Epidemiology of Prostate Cancer
2019 Standout
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
2009 StandoutNobel
Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
2011
Classification of Percutaneous Nephrolithotomy Complications Using the Modified Clavien Grading System: Looking for a Standard
2007 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Early Detection of Prostate Cancer: European Association of Urology Recommendation
2013
Novel Peptide Inhibitors of Human Kallikrein 2
2006
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy
2016
EAU Guidelines on Prostate Cancer
2007 Standout
Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?
2013
Prevention of Venous Thromboembolism
2004 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Prevalence and correlates of erectile dysfunction in Salvador, northeastern Brazil: a population-based study
2002
Prevention of Venous Thromboembolism
2008 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Antibiotic Prophylaxis in Urologic Procedures: A Systematic Review
2008
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
2018
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
The management of complex renal stones
2000
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Randomized Trial of Laparoscopic v Open Nephrectomy
2007
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction
2016
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Meta-analysis of the Complications of Laparoscopic Renal Surgery: Comparison of Procedures and Techniques
2006
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
LAPAROSCOPIC VERSUS OPEN RADICAL NEPHRECTOMY: A 9-YEAR EXPERIENCE
2000
Prognostic value of serum markers for prostate cancer
2005
Screening for prostate cancer
2013
CHAPTER 1: AUA GUIDELINE ON MANAGEMENT OF STAGHORN CALCULI: DIAGNOSIS AND TREATMENT RECOMMENDATIONS
2005 Standout
Screening for Prostate Cancer
2018
The Combination of Human Glandular Kallikrein and Free Prostate-specific Antigen (PSA) Enhances Discrimination Between Prostate Cancer and Benign Prostatic Hyperplasia in Patients with Moderately Increased Total PSA
1999
Prostate cancer screening in African American men: a review of the evidence
2023
Reconsidering the Trade-offs of Prostate Cancer Screening
2020
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Cancer statistics, 2016
2016 Standout
European Hernia Society guidelines on the treatment of inguinal hernia in adult patients
2009 Standout
Statistical assessment of the learning curves of health technologies
2001
UROLOGICAL COMPLICATIONS OF LAPAROSCOPIC SURGERY: EXPERIENCE WITH 350 PROCEDURES AT A SINGLE CENTER
2001
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
Screening for Prostate Cancer With the Prostate-Specific Antigen Test
2014
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Prostate-Specific Antigen–Based Screening for Prostate Cancer
2018
LAPAROSCOPIC NEPHRECTOMY FOR INFLAMMATORY RENAL CONDITIONS
2001
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting
2013
Works of Franz Recker being referenced
Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
2012
Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen
2000
Bacillus Calmette-Guérin Failure in Patients with Non–Muscle-invasive Urothelial Carcinoma of the Bladder May Be Due to the Urologist's Failure to Detect Urothelial Carcinoma of the Upper Urinary Tract and Urethra
2013
Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort
2011
In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL
1998
Incidence of Erectile Impotence Secondary to Transurethral Resection of Benign Prostatic Hyperplasia, Assessed by Preoperative and Postoperative Snap Gauge Tests
1995
PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE
2001
A Multicenter Clinical Trial On the Use of Complexed Prostate Specific Antigen in Low Prostate Specific Antigen Concentrations
2003
LAPAROSCOPIC NEPHRECTOMY: THE EXPERIENCE OF THE LAPAROSCOPY WORKING GROUP OF THE GERMAN UROLOGIC ASSOCIATION
1998
A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer ( ERSPC , Aarau)
2015